1 |
0,5 mg seasonal influenza vaccine i.m. |
- |
- |
- |
- |
051 [1] 51 💬 |
2 |
10% metronidazole ointment |
Metronidazole |
[3] D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
096 [1] 96 💬 |
3 |
13 valent conjugated pneumococcal vaccine |
- |
- |
- |
- |
265 [1] 265 💬 |
4 |
13-valent pneumococcal conjugate vaccine |
- |
- |
- |
- |
046 [2] 46, 53 💬 |
5 |
13-valent pneumococcal conjugate vaccine (13-pcv) |
- |
- |
- |
- |
013 [1] 13 💬 |
6 |
13-valent pneumococcal conjugated vaccine (pcv13) |
- |
- |
- |
- |
096 [1] 96 💬 |
7 |
2011-2012 seasonal flu vaccine intramuscular |
- |
- |
- |
- |
003 [2] 3 , 113 💬 |
8 |
2011-2012 seasonal flu vaccine subcutaneous |
- |
- |
- |
- |
003 [2] 3 , 113 💬 |
9 |
23-valent pneumococcal polysaccharide vaccine |
- |
- |
- |
- |
013 [3] 13, 46, 53 💬 |
10 |
23-valent pneumococcal polysaccharide vaccine (23-ppv) |
- |
- |
- |
- |
013 [1] 13 💬 |
11 |
23-valent polysaccharide pneumococcal vaccine |
- |
- |
- |
- |
096 [1] 96 💬 |
12 |
23-valent polysaccharide pneumococcal vaccine (pneumovax tm) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
13 |
5% lidocaine/5 mg/ml 0.02% estradiol compound cream |
Estradiol |
[11] D00105 D00105, D00358 D00358, D01413 D01413, D01617 D01617, D01953 D01953, D02086 D02086, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065, D08127 D08127 💬 |
ESR1 [7] ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [12] Adrenergic signaling in cardiomyocytes, Breast cancer, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway |
226 [1] 226 💬 |
14 |
7-valent pneumococcal conjugate vaccine |
- |
- |
- |
- |
046 [1] 46 💬 |
15 |
Abatacept + vaccines |
Abatacept |
[1] D03203 D03203 💬 |
CD80 [2] CD80, CD86 💬 |
Allograft rejection [12] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
046 [1] 46 💬 |
16 |
Agomelatine |
Agomelatine |
[1] D02578 D02578 💬 |
HTR2C [3] HTR2C, MTNR1A, MTNR1B 💬 |
Calcium signaling pathway [6] Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse |
006 [1] 6 💬 |
17 |
Agomelatine or piacebo |
Agomelatine |
[1] D02578 D02578 💬 |
HTR2C [3] HTR2C, MTNR1A, MTNR1B 💬 |
Calcium signaling pathway [6] Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse |
006 [1] 6 💬 |
18 |
Agrippal s1 (influenza vaccination) |
- |
- |
- |
- |
046 [1] 46 💬 |
19 |
Amoxicillin, metronidazole and tetracycline |
Amoxicillin |
[7] D00201 D00201, D00229 D00229, D00409 D00409, D02925 D02925, D05016 D05016, D05017 D05017, D07452 D07452 💬 |
- |
- |
097 [1] 97 💬 |
20 |
Anti-pandemic h1n1 influenza vaccine |
- |
- |
- |
- |
046 [5] 46, 49, 50, 51, 53 💬 |
21 |
Autologous adipose derived stromal vascular fraction |
- |
- |
- |
- |
096 [1] 96 💬 |
22 |
Autologous stromal vascular fraction (svf) |
- |
- |
- |
- |
085 [1] 85 💬 |
23 |
Autologous stromal vascular fraction cells |
- |
- |
- |
- |
046 [1] 46 💬 |
24 |
Autologous tissue-engineered vascular graft |
- |
- |
- |
- |
210 [1] 210 💬 |
25 |
Azd4017 and prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
26 |
Azithromycin + metronidazole |
Azithromycin |
[6] D00409 D00409, D02134 D02134, D05016 D05016, D05017 D05017, D06390 D06390, D07486 D07486 💬 |
- |
- |
096 [1] 96 💬 |
27 |
Bacille calmette-guerin vaccine |
- |
- |
- |
- |
013 [1] 13 💬 |
28 |
Beclomethasone dipropionate |
Beclomethasone dipropionate |
[2] D00689 D00689, D07495 D07495 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [2] 97, 98 💬 |
29 |
Belimumab plus early vaccination |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
30 |
Belimumab plus late vaccination |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
31 |
Benazepril, valsartan and fluvastatin |
Benazepril |
[5] D00400 D00400, D00620 D00620, D00892 D00892, D07499 D07499, D07983 D07983 💬 |
ACE [3] ACE, AGTR1, HMGCR 💬 |
AGE-RAGE signaling pathway in diabetic complications [22] AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
218 [1] 218 💬 |
32 |
Betamethasone |
Betamethasone |
[7] D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [6] 2 , 28, 46, 90, 96, 235 💬 |
33 |
Betamethasone acibutate |
Betamethasone |
[7] D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
34 |
Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days |
Acetate |
[7] D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [1] 2 💬 |
35 |
Bortezomib/dexamethasone |
Bortezomib |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150 💬 |
NR3C1 [2] NR3C1, PSMB5 💬 |
Alzheimer disease [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
283 [1] 283 💬 |
36 |
Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone |
Bortezomib |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150 💬 |
NR3C1 [2] NR3C1, PSMB5 💬 |
Alzheimer disease [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
028 [1] 28 💬 |
37 |
Bupivacaine/epinephrine/dexamethasone |
Bupivacaine |
[14] D00095 D00095, D00292 D00292, D00975 D00975, D00996 D00996, D01450 D01450, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02149 D02149, D02174 D02174, D02591 D02591, D02592 D02592, D07552 D07552 💬 |
ADRA1A [15] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
38 |
Cannabidiol vaginal suppository |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
226 [1] 226 💬 |
39 |
Capsaicin vapor |
Capsaicin |
[1] D00250 D00250 💬 |
TRPV1 [1] TRPV1 💬 |
Inflammatory mediator regulation of TRP channels [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
40 |
Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine |
Azathioprine |
[12] D00238 D00238, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D02994 D02994, D03033 D03033 💬 |
MS4A1 [2] MS4A1, NR3C1 💬 |
Hematopoietic cell lineage [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
035 [1] 35 💬 |
41 |
Combination product: beclomethasone dipropionate in addition to mc-evoo |
Beclomethasone dipropionate |
[2] D00689 D00689, D07495 D07495 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
42 |
Combination product: beclomethasone dipropionate in addition to refined oil |
Beclomethasone dipropionate |
[2] D00689 D00689, D07495 D07495 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
43 |
Combination therapy with vigabatrin and prednisolone |
Prednisolone |
[9] D00472 D00472, D00535 D00535, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
ABAT [2] ABAT, NR3C1 💬 |
Alanine, aspartate and glutamate metabolism [8] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
145 [1] 145 💬 |
44 |
Comparator: diclofenac |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
45 |
Comparator: diclofenac sodium |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
46 |
Conivaptan |
Conivaptan |
[2] D01236 D01236, D07748 D07748 💬 |
AVPR1A [2] AVPR1A, AVPR2 💬 |
Calcium signaling pathway [5] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption |
086 [1] 86 💬 |
47 |
Control intervention (no dexamethasone) |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
48 |
Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) |
Acetate |
[21] D00088 D00088, D00292 D00292, D00472 D00472, D00473 D00473, D00973 D00973, D00975 D00975, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D01998 D01998, D02156 D02156, D02174 D02174, D02591 D02591, D02592 D02592, D03301 D03301, D07749 D07749 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
49 |
Corticosteroid (prednisolone) |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
085 [1] 85 💬 |
50 |
Corticosteroid treatment (methylprednisolone or prednisolone) |
Methylprednisolone |
[14] D00407 D00407, D00472 D00472, D00751 D00751, D00979 D00979, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
064 [1] 64 💬 |
51 |
Corticosteroids (prednisone or prednisolone) |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
52 |
Cyclophosphamide, bortezomib, and dexamethasone (cybord) |
Bortezomib |
[12] D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150, D07760 D07760 💬 |
NR3C1 [2] NR3C1, PSMB5 💬 |
Alzheimer disease [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
028 [1] 28 💬 |
53 |
Cyclophosphamide, bortezomib, dexamethasone |
Bortezomib |
[12] D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150, D07760 D07760 💬 |
NR3C1 [2] NR3C1, PSMB5 💬 |
Alzheimer disease [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
028 [1] 28 💬 |
54 |
Cyclophosphamide, bortezomib, dexamethasone plus daratumumab |
Bortezomib |
[13] D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150, D07760 D07760, D10777 D10777 💬 |
CD38 [3] CD38, NR3C1, PSMB5 💬 |
Alzheimer disease [16] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia |
028 [1] 28 💬 |
55 |
Device: c-stem™ amt femoral component (standard and high off-set variants) |
- |
- |
- |
- |
046 [1] 46 💬 |
56 |
Device: dexamethasone injection |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
090 [1] 90 💬 |
57 |
Device: pleth variability index (pvi) |
- |
- |
- |
- |
070 [1] 70 💬 |
58 |
Device: sham vagus nerve stimulation |
- |
- |
- |
- |
046 [1] 46 💬 |
59 |
Device: transcutaneous electrical vagus nerve stimulation |
- |
- |
- |
- |
046 [1] 46 💬 |
60 |
Device: ultrasound vascularity |
- |
- |
- |
- |
096 [1] 96 💬 |
61 |
Device: vanguard 360 tinbn femur with ps bearing |
- |
- |
- |
- |
046 [1] 46 💬 |
62 |
Device: vanguard 360 tinbn femur with psc bearing |
- |
- |
- |
- |
046 [1] 46 💬 |
63 |
Device: vanguard da 360 |
- |
- |
- |
- |
046 [1] 46 💬 |
64 |
Device: vanguard ssk 360 with ps bearing |
- |
- |
- |
- |
046 [1] 46 💬 |
65 |
Device: vanguard ssk 360 with psc bearing |
- |
- |
- |
- |
046 [1] 46 💬 |
66 |
Dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [25] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
67 |
Dexamethasone (1 cycle) |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
68 |
Dexamethasone (4 cycles) |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
69 |
Dexamethasone (50mg 1dd6, 3 consecutive days/month) |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [1] 35 💬 |
70 |
Dexamethasone 0,1 mg tablets |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
71 |
Dexamethasone 0,5mg |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
72 |
Dexamethasone 0.5mg tablet |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
73 |
Dexamethasone 0.5mg/5ml solution |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [2] 35, 162 💬 |
74 |
Dexamethasone 0.5mg/5ml solution in mucolox™ |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [2] 35, 162 💬 |
75 |
Dexamethasone 1,5 mg tablets |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
76 |
Dexamethasone 21-dihydrogen phosphate |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
065 [1] 65 💬 |
77 |
Dexamethasone 21-phosphate |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
78 |
Dexamethasone 2mg tablets |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
79 |
Dexamethasone 4 mg jenapharm |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
028 [1] 28 💬 |
80 |
Dexamethasone abcur |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
81 |
Dexamethasone and rituximab |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D02994 D02994 💬 |
MS4A1 [2] MS4A1, NR3C1 💬 |
Hematopoietic cell lineage [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
82 |
Dexamethasone oral tablet 8mg (dexamethasone krka tablets(8mg), warsaw, poland). |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
235 [1] 235 💬 |
83 |
Dexamethasone parotid irrigation |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
053 [1] 53 💬 |
84 |
Dexamethasone sodium phosphate |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
065 [3] 65, 70, 96 💬 |
85 |
Dexamethasone sodium phosphate 250 mg/ 10 ml |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
86 |
Dexamethasone sodium phosphate 250 mg/10 ml solution |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
299 [1] 299 💬 |
87 |
Dexamethasone sodium phosphate ph. eur. |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
065 [1] 65 💬 |
88 |
Dexamethasone sodium sulfate |
Dexamethasone |
[11] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01732 D01732, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D05877 D05877 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
028 [1] 28 💬 |
89 |
Dexamethasone soduim phosphate |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
90 |
Dexamethasone, 40 mg |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
028 [1] 28 💬 |
91 |
Diagnostic test: dexamethasone test |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
92 |
Diazepam |
Diazepam |
[1] D00293 D00293 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
046 [3] 46, 155, 298 💬 |
93 |
Diazepam, melatonin |
Diazepam |
[2] D00293 D00293, D08170 D08170 💬 |
GABRA1 [18] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, MTNR1A, MTNR1B 💬 |
Circadian entrainment [8] Circadian entrainment, GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
046 [1] 46 💬 |
94 |
Diclofenac |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [4] 13, 34, 46, 271 💬 |
95 |
Diclofenac + omeprazole |
Diclofenac |
[7] D00455 D00455, D00903 D00903, D00904 D00904, D01207 D01207, D05259 D05259, D05261 D05261, D07816 D07816 💬 |
ATP4A [4] ATP4A, ATP4B, PTGS1, PTGS2 💬 |
Alzheimer disease [26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
96 |
Diclofenac 50 milligrams |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
271 [1] 271 💬 |
97 |
Diclofenac sodium |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
034 [2] 34, 46 💬 |
98 |
Diclofenac sodium topical gel |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
99 |
Diclofenac sr |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
271 [1] 271 💬 |
100 |
Enalapril |
Enalapril |
[2] D00621 D00621, D07892 D07892 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
019 [7] 19, 46, 66, 113, 210, 222, 223 💬 |
101 |
Enalapril and other angiotensin converting enzyme inhibitors |
Angiotensin II |
[4] D00150 D00150, D00621 D00621, D02014 D02014, D07892 D07892 💬 |
ACE [3] ACE, AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [18] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
019 [1] 19 💬 |
102 |
Enalapril maleate |
Enalapril |
[2] D00621 D00621, D07892 D07892 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
046 [1] 46 💬 |
103 |
Enalapril valsartan methylprednisone |
Enalapril |
[3] D00400 D00400, D00621 D00621, D07892 D07892 💬 |
ACE [2] ACE, AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [18] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [1] 66 💬 |
104 |
Epaxal berna (virosomal hepatitis a vaccine) |
Hepatitis A Vaccine |
- |
- |
- |
096 [2] 96, 97 💬 |
105 |
Estradiol |
Estradiol |
[8] D00105 D00105, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 [5] 13, 46, 49, 226, 299 💬 |
106 |
Estradiol 2 mg |
Estradiol |
[8] D00105 D00105, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
299 [1] 299 💬 |
107 |
Estradiol hemihydrate |
Estradiol |
[8] D00105 D00105, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 [1] 13 💬 |
108 |
Etanercept, methotrexate, prednisolone |
Etanercept |
[11] D00142 D00142, D00472 D00472, D00742 D00742, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02115 D02115, D02156 D02156, D03301 D03301 💬 |
DHFR [5] DHFR, DHFR2, LTA, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
056 [1] 56 💬 |
109 |
Ethinyl estradiol |
Estradiol |
[9] D00105 D00105, D00554 D00554, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
046 [3] 46, 49, 299 💬 |
110 |
Fendrix suspension for injection hepatitis b (rdna) vaccine (adjuvanted, adsorbed). |
- |
- |
- |
- |
046 [1] 46 💬 |
111 |
Focetria (monovalent mf59-adjuvanted vaccine) |
- |
- |
- |
- |
046 [3] 46, 49, 271 💬 |
112 |
Glucocorticoid (prednisone or prednisolone) |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
113 |
Hbvaxpro 5 micrograms/0.5 ml suspension for injection hepatitis b vaccine (rdna) |
Hepatitis B Vaccine (Recombinant) |
- |
- |
- |
046 [1] 46 💬 |
114 |
Hepatitis a vaccine |
Hepatitis A Vaccine |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
115 |
Hepatitis a vaccine ( havrix or epaxal) |
Hepatitis A Vaccine |
- |
- |
- |
046 [1] 46 💬 |
116 |
Hepatitis a vaccine and tetanus vaccine |
Hepatitis A Vaccine |
- |
- |
- |
046 [1] 46 💬 |
117 |
Hepatitis b vaccine |
Hepatitis B Vaccine (Recombinant) |
- |
- |
- |
046 [1] 46 💬 |
118 |
Hepatitis b vaccine (rdna) |
Hepatitis B Vaccine (Recombinant) |
- |
- |
- |
046 [1] 46 💬 |
119 |
Herpes zoster vaccine |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
120 |
High dose dexamethasone pulses |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
121 |
Histrelin |
Histrelin |
[1] D02369 D02369 💬 |
GNRHR [1] GNRHR 💬 |
GnRH signaling pathway [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction |
076 [1] 76 💬 |
122 |
Histrelin subcutaneous implant |
Histrelin |
[1] D02369 D02369 💬 |
GNRHR [1] GNRHR 💬 |
GnRH signaling pathway [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction |
076 [1] 76 💬 |
123 |
Hpv prophylactic vaccine gardasil |
- |
- |
- |
- |
049 [1] 49 💬 |
124 |
Human papillomavirus vaccination (gardasil) |
- |
- |
- |
- |
049 [1] 49 💬 |
125 |
Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten |
- |
- |
- |
- |
193 [1] 193 💬 |
126 |
Inactivated and fragmented influenza vaccine (a / michigan / 45/2015 (h1n1) pdm09-like virus, a / singapore / infimh-16-0019 / 2016 (h3n2) -like virus |
- |
- |
- |
- |
053 [1] 53 💬 |
127 |
Inactivated trivalent influenza vaccine |
- |
- |
- |
- |
063 [1] 63 💬 |
128 |
Influenza vaccination |
- |
- |
- |
- |
299 [1] 299 💬 |
129 |
Influenza vaccine |
- |
- |
- |
- |
011 [5] 11, 13, 46, 51, 84 💬 |
130 |
Influenza vaccine (surface antigen, inactivated) |
- |
- |
- |
- |
049 [1] 49 💬 |
131 |
Inhaled vancomycin |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
299 [1] 299 💬 |
132 |
Injection of autologous stromal vascular fraction |
- |
- |
- |
- |
051 [1] 51 💬 |
133 |
Intra-articular compound betamethasone |
Betamethasone |
[7] D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
134 |
Intraarticular betamethasone |
Betamethasone |
[7] D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
135 |
Intraarticular dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
136 |
Intravenous dexamethasone 1 mg |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
137 |
Intravenous methyl prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
043 [1] 43 💬 |
138 |
Iv vancomycin hydrochloride |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
299 [1] 299 💬 |
139 |
Lenalidomide and dexamethasone |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 [1] 16 💬 |
140 |
Lenalidomide+dexamethasone |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 [1] 16 💬 |
141 |
Lenalidomide, dexamethasone |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 [1] 16 💬 |
142 |
Lenalidomide, dexamethasone and cyclophosphamide |
Cyclophosphamide |
[12] D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687, D07760 D07760 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 [1] 28 💬 |
143 |
Lodotra (delayed release prednisolone) |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
144 |
Loestrin (norethindrone acetate and ethinyl estradiol) |
Acetate |
[11] D00105 D00105, D00182 D00182, D00554 D00554, D00953 D00953, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [3] ESR1, ESR2, PGR 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
299 [1] 299 💬 |
145 |
Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol) |
Acetate |
[11] D00105 D00105, D00182 D00182, D00554 D00554, D00953 D00953, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [3] ESR1, ESR2, PGR 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
046 [2] 46, 49 💬 |
146 |
Long-circulating liposomal prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
147 |
Low dose prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
148 |
Medium dose prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
149 |
Melphalan, thalidomide and dexamethasone |
Dexamethasone |
[11] D00292 D00292, D00369 D00369, D00754 D00754, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 [1] 28 💬 |
150 |
Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent) |
- |
- |
- |
- |
013 [1] 13 💬 |
151 |
Methotrexate - etanercept - prednisolone arm |
Etanercept |
[11] D00142 D00142, D00472 D00472, D00742 D00742, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02115 D02115, D02156 D02156, D03301 D03301 💬 |
DHFR [5] DHFR, DHFR2, LTA, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
152 |
Methyl prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
043 [3] 43, 49, 96 💬 |
153 |
Methylprednisolone or prednisolone |
Methylprednisolone |
[14] D00407 D00407, D00472 D00472, D00751 D00751, D00979 D00979, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
065 [1] 65 💬 |
154 |
Metronidazole |
Metronidazole |
[3] D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
046 [8] 46, 51, 63, 94, 95, 96, 97, 291 💬 |
155 |
Metronidazole capsule 50 mg |
Metronidazole |
[3] D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
097 [1] 97 💬 |
156 |
Mirapexin extended release various strengths |
- |
- |
- |
- |
006 [1] 6 💬 |
157 |
Mmf and dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
222 [1] 222 💬 |
158 |
Multi-modal pain management [valium + gabapentin] |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
070 [1] 70 💬 |
159 |
Multiple (4 autologous subcutaneous t cell vaccinations with t cell lines reactive to nine myelin peptides) |
- |
- |
- |
- |
013 [1] 13 💬 |
160 |
Needle biopsy of the vastus lateralis muscle |
- |
- |
- |
- |
113 [1] 113 💬 |
161 |
Oral prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [2] 49, 145 💬 |
162 |
Oral vancomycin |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
094 [2] 94, 296 💬 |
163 |
Ortho-cyclen, ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg |
Estradiol |
[10] D00105 D00105, D00554 D00554, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065, D05209 D05209 💬 |
ESR1 [3] ESR1, ESR2, PGR 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
299 [1] 299 💬 |
164 |
Other vasodilator |
- |
- |
- |
- |
051 [1] 51 💬 |
165 |
Other: vasculopathy assessment |
- |
- |
- |
- |
051 [1] 51 💬 |
166 |
Other: visual acuity (va) |
- |
- |
- |
- |
090 [2] 90, 301 💬 |
167 |
Overencapsulated prednisolone tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
168 |
Paroxetine & prednisolone |
Paroxetine |
[12] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02260 D02260, D02362 D02362, D03301 D03301, D05374 D05374, D05375 D05375 💬 |
NR3C1 [2] NR3C1, SLC6A4 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
046 [1] 46 💬 |
169 |
Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp |
Paroxetine |
[12] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02260 D02260, D02362 D02362, D03301 D03301, D05374 D05374, D05375 D05375 💬 |
NR3C1 [2] NR3C1, SLC6A4 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
046 [1] 46 💬 |
170 |
Paroxetine hydrochloride tablets 10 & 20 mg and prednisolone 1 mg bp |
Paroxetine |
[12] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02260 D02260, D02362 D02362, D03301 D03301, D05374 D05374, D05375 D05375 💬 |
NR3C1 [2] NR3C1, SLC6A4 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
046 [1] 46 💬 |
171 |
Pb1046, vip-elp1-120, vasomera |
- |
- |
- |
- |
086 [1] 86 💬 |
172 |
Peg-liposomal prednisolone sodium phosphate |
Phosphate ion |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [2] 13, 97 💬 |
173 |
Peri-neural dexamethasone 1 mg |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
174 |
Pertussis vaccine |
Pertussis vaccine |
[1] D06514 D06514 💬 |
- |
- |
046 [1] 46 💬 |
175 |
Phenylephrine |
Phenylephrine |
[2] D00511 D00511, D08365 D08365 💬 |
ADRA1A [3] ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
022 [1] 22 💬 |
176 |
Phosphate and betamethasone acetate, 2 ml. |
Acetate |
[7] D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
235 [1] 235 💬 |
177 |
Pneumococcal conjugate vaccine |
- |
- |
- |
- |
046 [1] 46 💬 |
178 |
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate |
Aluminium |
- |
- |
- |
046 [1] 46 💬 |
179 |
Pneumococcal polysaccharide vaccine |
- |
- |
- |
- |
046 [1] 46 💬 |
180 |
Pneumococcal polysaccharide vaccine (23 valent) |
- |
- |
- |
- |
046 [1] 46 💬 |
181 |
Pneumococcal polysaccharide vaccine 23 valent |
- |
- |
- |
- |
265 [1] 265 💬 |
182 |
Polidocanol |
Polidocanol |
[1] D01993 D01993 💬 |
- |
- |
279 [1] 279 💬 |
183 |
Pomalidomide and dexamethasone |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D08976 D08976 💬 |
IL6 [3] IL6, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [79] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 [1] 28 💬 |
184 |
Prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
185 |
Prednisolone & dipyridamole |
Dipyridamole |
[9] D00302 D00302, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [3] NR3C1, PDE4A, PDE5A 💬 |
Metabolic pathways [7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
186 |
Prednisolone + mabthera |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
061 [1] 61 💬 |
187 |
Prednisolone 1mg tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
188 |
Prednisolone 2,5 mg tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
189 |
Prednisolone 20 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
190 |
Prednisolone 40 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
191 |
Prednisolone 5 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [2] 46, 51 💬 |
192 |
Prednisolone 5 mg jenapharm |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
193 |
Prednisolone 5 mg tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
194 |
Prednisolone 5mg gastro-resistant tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
195 |
Prednisolone 5mg tablet |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
196 |
Prednisolone acetate |
Acetate |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
222 [1] 222 💬 |
197 |
Prednisolone and chlorambucil |
Chlorambucil |
[9] D00266 D00266, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
222 [1] 222 💬 |
198 |
Prednisolone and mycophenolate mofetil |
Mycophenolate mofetil |
[12] D00472 D00472, D00752 D00752, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [3] IMPDH1, IMPDH2, NR3C1 💬 |
Drug metabolism - other enzymes [4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism |
222 [1] 222 💬 |
199 |
Prednisolone and taper |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
200 |
Prednisolone labesfal |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
201 |
Prednisolone sodium metasulphobenzoate |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
202 |
Prednisolone sodium phosphate |
Phosphate ion |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [2] 13, 97 💬 |
203 |
Prednisolone sodium succinate |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
095 [1] 95 💬 |
204 |
Prednisolone tablets b.p. 5mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
205 |
Prednisolone tablets bp |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
206 |
Prednisolone tablets bp 1 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
207 |
Prednisolone tablets usp 5 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
208 |
Prednisolone-dipyridamole |
Dipyridamole |
[9] D00302 D00302, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [3] NR3C1, PDE4A, PDE5A 💬 |
Metabolic pathways [7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
209 |
Prednisolone/prednisone |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
210 |
Prednisone or prednisolone |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
211 |
Prednisone/prednisolone |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [1] 35 💬 |
212 |
Prevenar vaccination |
- |
- |
- |
- |
046 [1] 46 💬 |
213 |
Prevenar vaccine |
- |
- |
- |
- |
046 [1] 46 💬 |
214 |
Procedure: epidural steroid (dexamethasone) injection |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
215 |
Procedure: microcannula harvest adipose derived tissue stromal vascular fraction (tsvf) |
- |
- |
- |
- |
085 [2] 85, 229 💬 |
216 |
Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis a, hepatitis b, tick-borne encephalitis, meningococcal, pneumococcal) |
- |
- |
- |
- |
013 [1] 13 💬 |
217 |
Purified vero cell vaccine) |
- |
- |
- |
- |
065 [1] 65 💬 |
218 |
Pyridoxine plus prednisolone |
Prednisolone |
[10] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02179 D02179, D03301 D03301, D08454 D08454 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
145 [1] 145 💬 |
219 |
Quadrivalent influenza vaccine |
- |
- |
- |
- |
013 [1] 13 💬 |
220 |
Recombinant zoster vaccine |
- |
- |
- |
- |
049 [1] 49 💬 |
221 |
Remicade 100 mg infuusiokuiva-aine, konsentraattiliuosta varten |
- |
- |
- |
- |
097 [1] 97 💬 |
222 |
Rnl-vascostem® |
- |
- |
- |
- |
047 [1] 47 💬 |
223 |
Rt234 - vardenafil inhalation powder |
Vardenafil |
[3] D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
224 |
Sacubitril valsartan |
Sacubitril |
[2] D00400 D00400, D10225 D10225 💬 |
AGTR1 [2] AGTR1, MME 💬 |
AGE-RAGE signaling pathway in diabetic complications [19] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 [1] 58 💬 |
225 |
Sacubitril/valsartan |
Sacubitril |
[2] D00400 D00400, D10225 D10225 💬 |
AGTR1 [2] AGTR1, MME 💬 |
AGE-RAGE signaling pathway in diabetic complications [19] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 [1] 58 💬 |
226 |
Seasonal influenza vaccine |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
227 |
Seasonal influenza vaccine available for the 2012-2013 vaccine campaign |
- |
- |
- |
- |
084 [1] 84 💬 |
228 |
Seasonal quadrivalent influenza vaccine |
- |
- |
- |
- |
013 [1] 13 💬 |
229 |
Sodio valproato |
- |
- |
- |
- |
144 [1] 144 💬 |
230 |
Sodium valproate |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 [4] 2 , 90, 102, 256 💬 |
231 |
Sodium valproate 200 mg gastro-resistant tablets |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
233 [1] 233 💬 |
232 |
Sodium valproate 200mg e/c tablet |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
233 [1] 233 💬 |
233 |
Sodium valproate wockhardt 200mg gastro-resistant tablets |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
233 [1] 233 💬 |
234 |
Soluble prednisolone tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
145 [1] 145 💬 |
235 |
Spironolactone and conivaptan |
Conivaptan |
[3] D00443 D00443, D01236 D01236, D07748 D07748 💬 |
AVPR1A [3] AVPR1A, AVPR2, NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [6] Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption |
086 [1] 86 💬 |
236 |
Stromal vascular fraction |
- |
- |
- |
- |
051 [1] 51 💬 |
237 |
Stromal vascular fraction (svf) |
- |
- |
- |
- |
096 [1] 96 💬 |
238 |
Sulphasalazine + hydroxychloroquine or prednisolone |
Hydroxychloroquine |
[9] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D08050 D08050 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
239 |
T cell vaccination |
- |
- |
- |
- |
013 [1] 13 💬 |
240 |
T-cell vaccination |
- |
- |
- |
- |
013 [1] 13 💬 |
241 |
Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication) |
Amoxicillin |
[7] D00229 D00229, D00276 D00276, D00409 D00409, D02925 D02925, D05016 D05016, D05017 D05017, D07452 D07452 💬 |
- |
- |
063 [1] 63 💬 |
242 |
Tbe-vaccine |
- |
- |
- |
- |
046 [1] 46 💬 |
243 |
Tetanus + pnemococcal vaccines alone |
- |
- |
- |
- |
046 [1] 46 💬 |
244 |
Tetanus diphtheria toxoid vaccine (td) |
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) |
- |
- |
- |
013 [1] 13 💬 |
245 |
Tetanus diphtheria toxoids vaccine |
- |
- |
- |
- |
013 [1] 13 💬 |
246 |
Tetanus toxoid (tt) containing vaccine (td, tdap) |
Clostridium tetani toxoid antigen (formaldehyde inactivated) |
- |
- |
- |
013 [1] 13 💬 |
247 |
Tetanus toxoid adsorbed booster vaccine |
Clostridium tetani toxoid antigen (formaldehyde inactivated) |
- |
- |
- |
046 [1] 46 💬 |
248 |
Tetanus toxoid adsorbed vaccine |
Clostridium tetani toxoid antigen (formaldehyde inactivated) |
- |
- |
- |
046 [1] 46 💬 |
249 |
Tetanus toxoid vaccine |
Clostridium tetani toxoid antigen (formaldehyde inactivated) |
- |
- |
- |
013 [1] 13 💬 |
250 |
Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed) |
Clostridium tetani toxoid antigen (formaldehyde inactivated) |
[1] D06514 D06514 💬 |
- |
- |
046 [1] 46 💬 |
251 |
Tetanus vaccin |
- |
- |
- |
- |
011 [1] 11 💬 |
252 |
Tovaxin autologous t cell vaccine |
- |
- |
- |
- |
013 [1] 13 💬 |
253 |
Trexan+salazopyrin+oxiklorin+prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
254 |
Trexan+salazopyrin+oxiklorin+prednisolone + infliximab |
Infliximab |
[9] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02598 D02598, D03301 D03301 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
255 |
Trivalent inactivated influenza vaccine |
- |
- |
- |
- |
046 [1] 46 💬 |
256 |
Trivalent seasonal influenza vaccine |
- |
- |
- |
- |
013 [1] 13 💬 |
257 |
Tt vaccine |
- |
- |
- |
- |
013 [1] 13 💬 |
258 |
Va |
- |
- |
- |
- |
090 [3] 90, 301, 302 💬 |
259 |
Vaccin grippal pandémique h1n1 |
- |
- |
- |
- |
299 [1] 299 💬 |
260 |
Vaccination |
- |
- |
- |
- |
049 [1] 49 💬 |
261 |
Vaccination against tbe |
- |
- |
- |
- |
046 [1] 46 💬 |
262 |
Vaccination with vaccine against hepatitis a and b |
- |
- |
- |
- |
299 [1] 299 💬 |
263 |
Vaccine |
- |
- |
- |
- |
049 [1] 49 💬 |
264 |
Vaccine vivotif + vaccine dukoral |
- |
- |
- |
- |
097 [1] 97 💬 |
265 |
Vaccine vivotif + vaccine dukoral + oats |
Oat |
- |
- |
- |
097 [1] 97 💬 |
266 |
Vaginal estriol |
Estriol |
[2] D00185 D00185, D01986 D01986 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 [1] 13 💬 |
267 |
Val-1221 |
- |
- |
- |
- |
256 [1] 256 💬 |
268 |
Valacyclovir |
Valaciclovir |
[3] D00398 D00398, D08664 D08664, D10518 D10518 💬 |
- |
- |
065 [1] 65 💬 |
269 |
Valbenazine |
Valbenazine |
[1] D10675 D10675 💬 |
SLC18A2 [1] SLC18A2 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle |
008 [1] 8 💬 |
270 |
Valdecoxib |
Valdecoxib |
[1] D02709 D02709 💬 |
PTGS2 [1] PTGS2 💬 |
Alzheimer disease [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
271 |
Valerian |
Valerian |
- |
- |
- |
006 [1] 6 💬 |
272 |
Valganciclovir |
Valganciclovir |
[1] D02495 D02495 💬 |
- |
- |
028 [6] 28, 60, 85, 97, 299, 331 💬 |
273 |
Valganciclovir (vgc) |
Valganciclovir |
[1] D02495 D02495 💬 |
- |
- |
331 [1] 331 💬 |
274 |
Valganciclovir [valcyte] |
Valganciclovir |
[1] D02495 D02495 💬 |
- |
- |
299 [1] 299 💬 |
275 |
Valproate |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 [6] 2 , 3 , 90, 102, 233, 256 💬 |
276 |
Valproate sodium |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [1] 3 💬 |
277 |
Valproate, levocarnitine |
Levocarnitine |
[4] D00399 D00399, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [1] 3 💬 |
278 |
Valproic acid |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [10] 3 , 5 , 26, 34, 65, 89, 90, 222, 256, 331 💬 |
279 |
Valproic acid (vpa) |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [1] 3 💬 |
280 |
Valproic acid and levocarnitine |
Levocarnitine |
[4] D00399 D00399, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [1] 3 💬 |
281 |
Valproid acid plus corticosteroids |
- |
- |
- |
- |
026 [1] 26 💬 |
282 |
Valsartan |
Valsartan |
[1] D00400 D00400 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
057 [7] 57, 58, 66, 75, 218, 222, 224 💬 |
283 |
Vamarolone |
- |
- |
- |
- |
113 [1] 113 💬 |
284 |
Vaminolac |
- |
- |
- |
- |
097 [1] 97 💬 |
285 |
Vaminolac, komb. |
- |
- |
- |
- |
097 [1] 97 💬 |
286 |
Vamorolone |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [2] 97, 113 💬 |
287 |
Vamorolone 0.25 mg/day/day |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |
288 |
Vamorolone 0.25 mg/kg/day |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |
289 |
Vamorolone 0.75 mg/day/day |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |
290 |
Vamorolone 0.75 mg/kg/day |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |
291 |
Vamorolone 2.0 mg/day/day |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |
292 |
Vamorolone 2.0 mg/kg/day |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |
293 |
Vamorolone 4% suspension for oral dosing |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
294 |
Vamorolone 6.0 mg/day/day |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |
295 |
Vamorolone 6.0 mg/kg/day |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |
296 |
Vancomycin |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
046 [7] 46, 70, 94, 96, 97, 296, 299 💬 |
297 |
Vancomycin hydrochloride inhalation powder |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
299 [1] 299 💬 |
298 |
Vancomycin inhalation powder |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
299 [1] 299 💬 |
299 |
Vancomycin pre-treat |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
097 [1] 97 💬 |
300 |
Vancomycin pre-treatment |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
097 [1] 97 💬 |
301 |
Vantobra (tobramycin) |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
302 |
Vardenafil |
Vardenafil |
[3] D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
013 [3] 13, 86, 299 💬 |
303 |
Vardenafil (hidrocloride) |
Vardenafil |
[3] D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
304 |
Vardenafilo |
Vardenafil |
[3] D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
305 |
Vardenafilo hidrocloruro |
Vardenafil |
[3] D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
306 |
Varenicline |
Varenicline |
[1] D08669 D08669 💬 |
CHRNA4 [2] CHRNA4, CHRNB2 💬 |
Cholinergic synapse [3] Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction |
006 [2] 6 , 18 💬 |
307 |
Varenicline tartrate |
Varenicline |
[1] D08669 D08669 💬 |
CHRNA4 [2] CHRNA4, CHRNB2 💬 |
Cholinergic synapse [3] Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction |
006 [1] 6 💬 |
308 |
Vari |
- |
- |
- |
- |
062 [2] 62, 274 💬 |
309 |
Variation of behaviors of parkinson's disease |
- |
- |
- |
- |
006 [1] 6 💬 |
310 |
Varicella zoster vaccine |
- |
- |
- |
- |
046 [1] 46 💬 |
311 |
Vaseline |
- |
- |
- |
- |
051 [1] 51 💬 |
312 |
Vasoactive intestinal peptide |
- |
- |
- |
- |
085 [1] 85 💬 |
313 |
Vasomera (pb1046) injection |
- |
- |
- |
- |
086 [1] 86 💬 |
314 |
Vasopressin |
Vasopressin |
[1] D00101 D00101 💬 |
AVPR1A [3] AVPR1A, AVPR1B, AVPR2 💬 |
Calcium signaling pathway [5] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption |
210 [1] 210 💬 |
315 |
Vasopressin, arginine |
Arginine |
[2] D00101 D00101, D02982 D02982 💬 |
AVPR1A [3] AVPR1A, AVPR1B, AVPR2 💬 |
Calcium signaling pathway [5] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption |
210 [1] 210 💬 |
316 |
Vastarel |
- |
- |
- |
- |
058 [1] 58 💬 |
317 |
Vastarel 20mg film coated tablets |
- |
- |
- |
- |
058 [1] 58 💬 |
318 |
Vatelizumab |
Vatelizumab |
- |
- |
- |
013 [2] 13, 97 💬 |
319 |
Vatiquinone |
Vatiquinone |
[1] D10407 D10407 💬 |
- |
- |
018 [2] 18, 21 💬 |
320 |
Vay736 |
- |
- |
- |
- |
013 [7] 13, 35, 46, 49, 53, 85, 95 💬 |
321 |
Vay736 antibody |
- |
- |
- |
- |
053 [1] 53 💬 |
322 |
Vay736 higher dose |
- |
- |
- |
- |
053 [1] 53 💬 |
323 |
Vay736 lower dose |
- |
- |
- |
- |
053 [1] 53 💬 |
324 |
Verapamil |
Verapamil |
[2] D00619 D00619, D02356 D02356 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [3] 96, 140, 167 💬 |
325 |
Verapamil sr |
Verapamil |
[2] D00619 D00619, D02356 D02356 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
167 [1] 167 💬 |
326 |
With u-vanco (vancomycin hydrochloride) |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
070 [1] 70 💬 |
327 |
Without u-vanco (vancomycin hydrochloride) |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
070 [1] 70 💬 |
328 |
Yellow fever vaccine |
Yellow Fever Vaccine |
[1] D06347 D06347 💬 |
- |
- |
040 [7] 40, 44, 46, 50, 51, 52, 53 💬 |
329 |
Yellow fever vaccine (17d) |
Yellow Fever Vaccine |
[1] D06347 D06347 💬 |
- |
- |
040 [7] 40, 44, 46, 50, 51, 52, 53 💬 |
330 |
Z102 (prednisolone and dipyridamole). |
Dipyridamole |
[9] D00302 D00302, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [3] NR3C1, PDE4A, PDE5A 💬 |
Metabolic pathways [7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
331 |
Zostavax (varicella zoster virus) vaccine |
- |
- |
- |
- |
046 [1] 46 💬 |
332 |
Zostavax vaccine |
- |
- |
- |
- |
046 [2] 46, 49 💬 |